A Phase II Evaluation of a 3-Hour Infusion of Paclitaxel, Cisplatin, and 5-Fluorouracil in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Cancer - United States
doi 10.1002/cncr.21994
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2006
Authors
Publisher
Wiley-Blackwell